Nasal Vaccination Improves COVID-19 Protection In Australia
Researchers from Australia's Centenary Institute and the University of Sydney have created a novel nasal vaccination system that promotes strong lung resistance and tolerance...
Kidney Cancer UK Gains Breakthrough NICE Clinical Funding
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to gain funding for the National Institute for Health and...
Oxford Researchers Uncover The Root Behind Type 2 Diabetes
The root cause of type 2 diabetes has been clarified by a new study, which shows that elevated blood glucose alters the metabolism of...
First Implanted Pump Makes Use of Chemo To Cure Brain Cancer
In a Phase I study that was recently published in the journal Lancet Oncology, it was shown that the first implantable pump system for...
Research Offers Neurodegenerative Disease Patients Optimism
The development of a neurodegenerative disease in mice is slowed down by a novel therapy, according to researchers. The ground-breaking study may provide hope...
5 COVID Therapies Are Not Cost-Effective, According To NICE
Five COVID-19 therapies, including Merck & Co.'s antiviral tablet for high-risk patients, have been recommended for discontinuation by Britain's agency that decides whether medications...
Pharma In Africa Needs Indigenous Emphasis And Investment
The growth of the domestic pharmaceutical industry and a reduction in reliance on imports might be facilitated by funding AI-based research and development and...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...